Avantor, Inc. (NYSE:AVTR) Shares Sold by Goldman Sachs Group Inc.

Goldman Sachs Group Inc. trimmed its stake in Avantor, Inc. (NYSE:AVTRFree Report) by 30.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 785,764 shares of the company’s stock after selling 341,660 shares during the quarter. Goldman Sachs Group Inc. owned approximately 0.12% of Avantor worth $17,939,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in AVTR. Mariner LLC grew its stake in Avantor by 17.3% in the 3rd quarter. Mariner LLC now owns 42,025 shares of the company’s stock worth $886,000 after acquiring an additional 6,196 shares during the period. Northern Trust Corp increased its stake in Avantor by 9.0% in the third quarter. Northern Trust Corp now owns 4,129,447 shares of the company’s stock valued at $87,049,000 after purchasing an additional 342,553 shares during the last quarter. Treasurer of the State of North Carolina lifted its position in Avantor by 0.4% during the third quarter. Treasurer of the State of North Carolina now owns 313,496 shares of the company’s stock worth $6,608,000 after buying an additional 1,187 shares during the period. Tower Research Capital LLC TRC boosted its stake in Avantor by 170.4% in the 3rd quarter. Tower Research Capital LLC TRC now owns 24,722 shares of the company’s stock worth $521,000 after buying an additional 15,580 shares during the last quarter. Finally, Bank of Nova Scotia boosted its stake in Avantor by 18.1% in the 3rd quarter. Bank of Nova Scotia now owns 16,024 shares of the company’s stock worth $338,000 after buying an additional 2,455 shares during the last quarter. 95.08% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research analysts have recently weighed in on AVTR shares. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Avantor from $23.00 to $25.00 and gave the stock a “hold” rating in a report on Thursday, April 18th. Robert W. Baird lowered their price objective on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a research note on Monday, April 29th. Evercore ISI increased their target price on Avantor from $26.00 to $28.00 and gave the stock an “outperform” rating in a research report on Thursday, April 4th. Finally, Barclays boosted their price target on Avantor from $27.00 to $30.00 and gave the company an “overweight” rating in a research report on Wednesday, April 10th. Four investment analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $26.71.

Check Out Our Latest Report on Avantor

Avantor Stock Down 2.4 %

NYSE AVTR opened at $21.42 on Friday. The company has a quick ratio of 1.05, a current ratio of 1.61 and a debt-to-equity ratio of 0.94. Avantor, Inc. has a fifty-two week low of $16.63 and a fifty-two week high of $26.16. The business has a 50 day moving average price of $23.85 and a two-hundred day moving average price of $23.81. The stock has a market cap of $14.55 billion, a PE ratio of 54.92, a P/E/G ratio of 2.24 and a beta of 1.35.

Avantor (NYSE:AVTRGet Free Report) last announced its earnings results on Friday, April 26th. The company reported $0.22 earnings per share for the quarter, beating the consensus estimate of $0.20 by $0.02. Avantor had a net margin of 3.79% and a return on equity of 13.01%. The business had revenue of $1.68 billion during the quarter, compared to the consensus estimate of $1.68 billion. During the same period in the prior year, the firm earned $0.29 earnings per share. The business’s quarterly revenue was down 5.6% compared to the same quarter last year. As a group, sell-side analysts predict that Avantor, Inc. will post 1.01 EPS for the current fiscal year.

About Avantor

(Free Report)

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

Featured Articles

Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTRFree Report).

Institutional Ownership by Quarter for Avantor (NYSE:AVTR)

Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.